Plcoskin

About:

Plcoskin is a MedTech company specializing in reconstructive plastic surgery and regenerative skincare.

Website: https://plcoskin.com

Top Investors: Primer, TIPS Program, TiPS, We Ventures, SJ Investment Partners

Description:

Plcoskin is a MedTech company specializing in reconstructive plastic surgery and regenerative skincare. They have developed a scaffold that removes the need for cadaver-sourced material used in breast reconstruction surgery, making procedures safer and cheaper. Plcoskin’s scaffolds are made with synthetic PCL, a biodegradable material that is commonly used to create surgical sutures. Unlike competitors' products that remain in the body for a lifetime, Plcoskin’s PCL scaffolds are absorbed and replaced with the recipient’s own natural tissues, minimizing the possibility of long-term side effects. As they do not contain any dangerous chemicals, they are also 50% safer than cadaver-sourced scaffolds. Costs for reconstructive breast surgery are brought down by 40% to only $3 thousand per breast. Furthermore, much less handling time is required, reducing average surgery durations from an hour and a half to only 30 minutes. The mesh design of the scaffolds mitigates the need for an additional follow-up reconstructive surgery, something that is common when using cadaver-sourced scaffolds. Plcoskin has also developed Youlief, a cosmeceutical product & therapeutic device pipeline that helps fund R&D for their medical devices. Youlief is available in the US, Europe, Taiwan, Singapore and Japan.

Total Funding Amount:

900M KRW

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2017-02-03

Contact Email:

master(AT)plcoskin.com

Founders:

Woo Yeol Baek

Number of Employees:

1-10

Last Funding Date:

2023-08-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai